Possible involvement of dopaminergic neurotransmitter system in dichlorvos induced delayed neurotoxicity

Journal of Biochemistry, Molecular Biology and Biophysics

Volumn 6, Issue 1, 2002, Pages 29-36

  Choudhary, Sanjeev ^a   Raheja, Geetu ^a   Gupta, Vandana ^a   Gill, Kiran Dip ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Delayed neurotoxicity; Dichlorvos; Dopamine; Nimodipine

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; DICHLORVOS; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; NEUROTRANSMITTER; NIMODIPINE; NORADRENALIN; ORGANOPHOSPHATE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATECHOLAMINE SYNTHESIS; CONTROLLED STUDY; DELAYED NEUROTOXICITY; DOPAMINE BLOOD LEVEL; DOPAMINERGIC SYSTEM; DRUG EFFICACY; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; NEUROPROTECTION; NONHUMAN; NORADRENALIN BLOOD LEVEL; RAT; REFERENCE VALUE; SCATCHARD PLOT;

ANIMALS; CALCIUM CHANNEL BLOCKERS; DICHLORVOS; DOPAMINE; DOPAMINE BETA-HYDROXYLASE; INJECTIONS, SUBCUTANEOUS; INSECTICIDES; MALE; MONOAMINE OXIDASE; MOTOR ACTIVITY; NEUROTOXICITY SYNDROMES; NIMODIPINE; NOREPINEPHRINE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; TYROSINE 3-MONOOXYGENASE;

ANIMALIA;

EID: 0036486811     PISSN: 10258140     EISSN: None     Source Type: Journal    
DOI: 10.1080/10258140290010197     Document Type: Article

References (25)

1. Siwatch, S.B. and Gupta, A. (1995) "The profile of acute poisoning in Haryana-Rohtak study", JAPI 43, 756-759.
2. Carod-Artal, F.J. and Speck-Martins, C. (1999) "Late onset polyneuropathy due to exposure to organophosphates", Rev. Neurol. 29, 123-137.
3. Randall, J.C., Yano, B.L. and Richardson, R.J. (1997) "Potentiation of organophosphorus compound induced delayed neurotoxicity (OPIDN) in the central and peripheral nervous system of the adult hen: distribution of axonal lesions", J. Toxicol. Environ. Health 51, 571-590.
4. Burn, J.H. and Rand, N.J. (1965) "Ach in adrenergic transmission", Ann. Rev. Pharmacol. 5, 163-180.
5. Ali, S.F., Chandra, O. and Hassan, M. (1980) "Effects of an organophosphate (Dichlorvos) on open field behaviour and locomotor activity: correlation with regional brain monoamine levels", Psychopharmacology 68, 37-47.
6. Knoth-Anderson, J. and Abou-Donia, M.B. (1993) "Differential effects of triphenylphosphite and diisopropyl phosphofluoridate on catecholamine secretion from bovine adrenomedullary chromaffin cells", J. Toxicol. Environ. Health 38, 103-114.
7. McCain, W.C., Flaherty, D.M., Correll, L., Jortner, B. and Ehirch, M. (1996) "Catecholamine concentrations and contractile responses of isolated vessels from hens treated with cyclic phenyl saligenin phosphate or paraxon in the presence or absence of verapamil", J. Toxicol. Environ. Health 48, 397-411.
8. El-Fawal, H.A.N., Jortner, B.S. and Ehrich, M. (1989) "Effect of verapamil on organophosphate-induced delayed neuropathy (OPIDN) in hens", Toxicol. Appl. Pharmacol. 97, 500-511.
9. El-fawal, H.A.N., Correll, L., Gay, L. and Ehrich, M. (1990) "Protease activity in brain, nerve and muscle of hens given neuropathy-inducing organophosphates and a calcium channel blocker", Toxicol. Appl. Pharmacol. 103, 133-142.
10. Gispen, W.H. and Hamers, F.P.T. (1994) "Calcium and neuronal dysfunction in peripheral nervous system", Ann. N.Y. Acad. Sci. 747, 419-430.
11. Tollefson, G.D. (1990) "Short term effects of calcium channel blocker nimodipine (Bay-e-9736) in the management of primary degenerative dementia", Biol. Psychiatry 27, 1133-1142.
12. DeJonge, M., Friedel, A. and De Vrij, C.N.S. (1993) "Pharmacology of nimodipine. Antidepressant effects, drug discrimination and Ca2+ imaging", Ca2+ antagonist in the CNS. Drugs in development (Neva Press, Connecticut) Vol. 2A, pp 165-174.
13. Cox, R.H. and Perhach, J.L. (1973) "A sensitive, rapid and simple method for the simultaneous spectrophotofluorometric determination of nor-epinephrine, dopamine and 5-hydroxytryptamine in discrete areas of brain", J. Neurochem. 20, 1777-1780.
14. Ansell, G.B. and Beeson, M.F. (1968) "A rapid and sensitive procedure for the combined assay of noradrenaline, dopamine and serotonin in a single brain sample", Anal. Biochem. 23, 196-206.
15. McGeer, E.G. and McGeer, P.L. (1967) "In vitro screen of inhibitions of rat brain tyrosine hydroxylase", Can. J. Biochem. 45, 115-131.
16. McEwen, C.M. and Cohen, J.D. (1963) "An amine oxidase in normal human serum", J. Lab. Clin. Med. 62, 766-776.
17. Kato, T., Yoshiko, W. and Nagatsu, T. (1978) "An improved dual wavelength spectrophotometric assay for dopamine-b-hydroxylase", Biochem. Pharmacol. 27, 829-831.
18. Briley, M. and Langer, S.Z. (1978) "Two binding sites for 3H spiroperidol on rat striated membranes", Eur. J. Pharmacol. 50, 283-284.
19. Scatchard, G. (1949) "The alterations of proteins for small molecules and ions", Ann. N.Y. Acad. Sci. 51, 660-672.
20. Civelli, O., Bunzow, J.R. and Grandy, D.K. (1993) "Molecular diversity of the dopamine receptors", Ann. Rev. Pharmacol. Toxicol. 32, 281-287.
21. Breese, G.R., Nbaumeister, A., Napier, T.C., Frye, G. and Mueller, R.A. (1985) "SCH 23390 may alter dopamine mediated motor behaviour via striatal D2 receptors", Biochem. Pharmacol. 34, 1665-1669.
22. Sarin, S. and Gill, K.D. (2000) "Biochemical characterization of dichlorvos induced delayed neurotoxicity in rat", IUBMB Life 49, 125-130.
23. Matussek, N. and Ruther, E. (1965) "Wirkungsmechanismus der Reserpinunkehr mit desmethylimipramin", Med. Pharmacol. Exp. 12, 217-225.
24. Bowyer, J.F., Nakanishi, A., Houchi, H., Dreyer, E., Sterling, C., Masserano, J.S., Tank, A.W. and Weiner, N. (1992) "Phosphorylation and activation of tyrosine hydroxylase in PC 18 cells: a cell line derived from rat pheochromocytoma PC 12 cells", Brain Res. 591, 261-270.
25. Glisson, S.N., Karczmar, A.G. and Bardes, L. (1974) "Effect of diisopropyl phosphofluoridate on acetylcholine, cholinesterase and catecholines of several parts of rabbit bran", Neuropharmacology 13, 623-631.